Growing use of synthetic marijuana cannabinoids is to blame for a 229% increase in suspected poisonings earlier this year, the Centers for Disease Control and Prevention reported today. Between January and May 2015, U.S. poison centers in 48 states reported receiving 3,572 calls related to synthetic cannabinoid use, compared to about 1,085 calls during the same time period in 2014. The 2015 figures included a spike of 1,501 calls in April, and 15 reported deaths, a three-fold increase over the five deaths reported in 2014. Synthetic cannabinoids include a range of psychoactive chemicals that are sprayed onto plant material, and then smoked or ingested. The findings suggest that synthetic cannabinoids “pose an emerging public threat … and a need for greater public health surveillance and awareness, targeted public health messaging, and enhanced efforts to remove these products from the market,” the report said. 

Headline
The AHA Aug. 31 submitted comments urging the National Association of Insurance Commissioners Health Care Affordability and Mitigation Working Group to take a…
Headline
The House voted Sept. 1 on a continuing resolution (H.R. 6500) to fund the federal government through Dec. 11. The measure passed on a 370-48 bipartisan vote;…
Headline
The Trump administration announced Aug. 31 agreements with nine additional pharmaceutical manufacturers aimed at lowering prescription drug prices through a…
Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…
Headline
This webinar explores how hospital and health system leaders can prepare for Medicare Advantage’s new electronic prior authorization mandate, which goes into…
Headline
The Food and Drug Administration has identified a Class I recall of certain convenience kits by AVID Medical that contain recalled Medline Namic Angiographic…